Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.

Transforming growth factor betas (TGF-betas) are a growth factor family with negative autocrine growth functions for most epithelial cells including colon carcinoma cell lines. Both type I (RI) and type II (RII) transmembrane TGF-beta receptors have been shown to be indispensable for TGF-beta-mediated cell growth regulation. Previous studies using different model systems have shown that both overexpression of TGF-beta1 and transfection of antisense TGF-beta1 to reduce TGF-beta1 expression could lead to increased tumorigenicity. These results are seemingly contradictory and suggest that effects of TGF-beta modulation on malignant properties of cancer cells may be contextual. This study addresses this issue using human colon carcinoma cells (CBS and FET) to determine the effects of modulation of the various components of the TGF-beta system on in vitro and in vivo growth properties in two independent isogenic models of colon carcinoma. Cells were stably transfected with a tetracycline-repressible RII expression vector (CBS4-RII), a tetracycline-repressible expression vector containing a truncated RII cDNA lacking the serine/threonine kinase domain (CBS4-deltaRII and FET6-deltaRII), or with a vector containing the TGF-beta1 cDNA (CBS4-beta1S and FET-beta1S). Expression of the truncated RII reduced TGF-beta sensitivity, whereas overexpression of RII increased TGF-beta sensitivity. TGF-beta overexpression did not affect TGF-beta response. In vivo tumorigenicity assays revealed that CBS4-RII cells had lower tumorigenicity than control cells, whereas CBS4-deltaRII and CBS4-beta1S had higher tumorigenicity than controls. The CBS4 cells are poorly tumorigenic in athymic mice, and the wild-type FET6 cells are nontumorigenic. FET6-deltaRII cells formed rapidly growing tumors, and FET-beta1S cells also formed tumors. These data illustrate the paradoxical tumor-promoting and -suppressing effects of TGF-beta signaling activity in two isogenic model systems from human colon carcinomas, thus demonstrating that the effects of modulation of TGF-beta expression or TGF-beta signaling capability affects malignancy in a contextual manner.

[1]  J. Massagué,et al.  TGF‐β Receptors and TGF‐β Binding Proteoglycans: Recent Progress in Identifying Their Functional Properties , 1990 .

[2]  J. Willson,et al.  Autocrine Transforming Growth Factor α Provides a Growth Advantage to Malignant Cells by Facilitating Re-entry into the Cell Cycle from Suboptimal Growth States* , 1998, The Journal of Biological Chemistry.

[3]  Luzhe Sun,et al.  Expression of Transforming Growth Factor β (TGFβ) Type III Receptor Restores Autocrine TGFβ1 Activity in Human Breast Cancer MCF-7 Cells* , 1997, The Journal of Biological Chemistry.

[4]  A. Kasid,et al.  Expression of Transforming Growth Factor α in Normal Human Adult Kidney and Enhanced Expression of Transforming Growth Factors α and β1 in Renal Cell Carcinoma , 1989 .

[5]  W. Sosroseno,et al.  The immunoregulatory roles of transforming growth factor beta. , 1995, British journal of biomedical science.

[6]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[7]  M. Steiner,et al.  Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. , 1992, Molecular endocrinology.

[8]  C. Arteaga,et al.  Blockade of Transforming Growth Factor-β Signaling Does Not Abrogate Antiestrogen-induced Growth Inhibition of Human Breast Carcinoma Cells* , 1997, The Journal of Biological Chemistry.

[9]  K. M. Mulder,et al.  Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells. , 1989, Molecular endocrinology.

[10]  김성진.  Transforming Growth Factor-βs , 1996 .

[11]  A. Manning,et al.  Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. , 1991, Oncogene.

[12]  Luzhe Sun,et al.  Autocrine transforming growth factor-β1 and β2 expression is increased by cell crowding and quiescence in colon carcinoma cells , 1994 .

[13]  Y. Niitsu,et al.  Expression of TGF-beta gene in adult T cell leukemia. , 1988, Blood.

[14]  M. Brattain,et al.  Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose. , 1988, Cancer research.

[15]  F. Ruscetti,et al.  Pleiotropic Effects of Transforming Growth Factor‐β on Cells of the Immune System , 1993, Annals of the New York Academy of Sciences.

[16]  W. Linehan,et al.  Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma. , 1989, Cancer research.

[17]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[18]  S. Kawata,et al.  Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. , 1991, Cancer research.

[19]  M. Sporn,et al.  Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. , 1986, Journal of immunology.

[20]  K. Miyazono,et al.  Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.

[21]  M. Mukai,et al.  Potentiation of Invasive Capacity of Rat Ascites Hepatoma Cells by Transforming Growth Factor‐β , 1989, Japanese journal of cancer research : Gann.

[22]  C. Osborne,et al.  Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells , 1988 .

[23]  M. Sporn,et al.  Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Luzhe Sun,et al.  Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*) , 1995, The Journal of Biological Chemistry.

[26]  J. Willson,et al.  Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[27]  H. Lodish,et al.  A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma , 1996, Molecular and cellular biology.

[28]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[29]  A. Rizzino,et al.  Preparation and binding of radioactively labeled porcine transforming growth factor type beta. , 1986, Biochemical and biophysical research communications.

[30]  J. Willson,et al.  Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells , 1994 .

[31]  A. Levinson,et al.  Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1 , 1990, The Journal of experimental medicine.

[32]  R. Derynck,et al.  Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1 , 1992, The Journal of cell biology.

[33]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[34]  H. Sambrook.  Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[35]  J. Willson,et al.  TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector , 1992, The Journal of cell biology.

[36]  K. Boo-Chai.  Growth factor expression in normal, benign, and malignant breast tissue , 1989 .

[37]  J. Massagué,et al.  TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties. , 1990, Annals of the New York Academy of Sciences.

[38]  F. Ruscetti,et al.  Transforming growth factor- and the immune system , 1991 .

[39]  J. Massagué,et al.  Signaling Activity of Homologous and Heterologous Transforming Growth Factor-β Receptor Kinase Complexes (*) , 1995, The Journal of Biological Chemistry.

[40]  M. Sporn,et al.  The Transforming Growth Factor-βs , 1991 .

[41]  M. Jaye,et al.  Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia , 1990, The Prostate.

[42]  H. Moses,et al.  Transforming growth factors and the regulation of cell proliferation. , 1990, European journal of biochemistry.

[43]  J. Massagué,et al.  TGF beta signals through a heteromeric protein kinase receptor complex. , 1992, Cell.

[44]  A. Roberts,et al.  Membrane binding characteristics of two forms of transforming growth factor-beta. , 1987, The Journal of biological chemistry.

[45]  J. Massagué,et al.  Loss of receptors for transforming growth factor beta in human T-cell malignancies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Hada,et al.  Potentiation of Metastatic Capacity by Transforming Growth Factor‐β1 Gene Transfection , 1993, Japanese journal of cancer research : Gann.

[47]  K. M. Mulder,et al.  Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. , 1989, Experimental cell research.

[48]  M. L. Gustafson,et al.  A transforming growth factor beta type I receptor that signals to activate gene expression. , 1994, Science.

[49]  H. Moses,et al.  Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane , 1990, The Journal of cell biology.

[50]  M. Sporn,et al.  The Transforming Growth Factor‐Betas: Past, Present, and Future , 1990, Annals of the New York Academy of Sciences.